Formulation and evaluation of monolithic matrix polymer films for transdermal delivery of nitrendipine

Acta Pharmaceutica

Volumn 59, Issue 4, 2009, Pages 383-393

  Mittal, Ashu ^a   Sara, Udai ^b   Ali, Asgar ^c  

^a ITS Paramedical College (Pharmacy)   (India)

^b DJ College of Pharmacy   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Eudragit RL 100; Nitrendipine; Plasdone S 630; Polymeric film; PVP K 30; Transdermal drug delivery

Indexed keywords

EUDRAGIT; MERCURY; NITRENDIPINE; POLYMER; POVIDONE;

ARTICLE; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; EPIDERMIS; HUMAN; INFRARED SPECTROSCOPY; SKIN PERMEABILITY; THIN LAYER CHROMATOGRAPHY;

EID: 77949426108     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0032-9     Document Type: Article

References (15)

1. N. T. Dnyanesh and P. R. Vavia, Acrylate-based transdermal therapeutic system of nitrendipine, Drug Dev. Ind. Pharm. 29 (2003) 71-78; DOI: 10.1081/DDC-1200166851.
2. B. W. Barry, Dermatological Formulation, Marcel Dekker, New York 1983, pp. 225-238.
3. G. R. Aronoff and R. S. Sloan, Nitrendipine kinetics in normal and impaired renal function, Clin. Pharmacol. Ther. 38 (1985) 212-218; DOI: 10.1038/clpt.1985.161.
4. A. Mittal, U. V. S. Sara, A. Asgar and M. Aqil, The effect of penetration enhancers on permeation kinetics of nitrendipine in two different skin models, Biol. Pharm. Bull. 31 (2008) 1766-1772; DOI: 10.1248/bpb.31.1766.
5. M. Aqil, A. Ali, Y. Sultana and P. Nayyar, Matrix type transdermal drug delivery systems of metoprolol tartrate: skin toxicity and in vivo characterization, Ethiop. Pharm. J. 22 (2004) 53-60.
6. P. Arora and M. Biswajit, Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containg diclofenac diethylammonium salt, J. Pharm. Sci. 91 (2002) 2076-2089; DOI: 10.1002/jps.10200.
7. Udhumansha, M. V. S. Reddy, R. Kumaresan, F. J. Ahmad and R. K. Khar, Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics, AAPS PharmSciTech. 8 (2007) 1-8; DOI: 10.1208/pt0801002.
8. P. Costa and S. J. M. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/s0928-0987(01) 00095-1.
9. J. Reichling, U. Landvatter, H. Wagner, H. K. Kostka and F. U. Schaefer, In vitro studies on release and human skin permeation of Australian tea tree oil from topical formulations, Eur. J. Pharm. Biopharm. 64 (2006) 222-228; DOI: 10.1016/j.ejpb.2006.05.006.
10. S. Sonkro, Y. Purwo, G. Becket and T. Rades, Investigation of newborn pig skin as an in vitro animal model for transdermal drug delivery, STP Pharm. Sci. 13 (2003) 133-139.
11. A. P. Kakkar and A. Gupta, Gelatin based transdermal therapeutic system, Indian Drug 29 (1992) 308-312.
12. H. K. Vaddi, P. C. Ho and S. Y. Chan, Terpenes in propylene glycol as skin penetration enhancers: Permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry, J. Pharm. Sci. 91 (2002) 1639-1651; DOI: 10.1002/jps.10160.
13. D. Bommannan, R. O. Potts and R. H. Guy, Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Control. Rel. 16 (1991) 299-304; DOI: 10.1016/0168-3659(91)90006-Y.
14. O. Yasuko, T. Kozo, M. Yoshie, M. Yoshiharu and T. Nagai, Effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J.Pharm. 89 (1993) 191-198; DOI: 10.1016/0378-5173 (93)90243-90249
15. P. R. Roa and P. V. Diwan, Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration, Drug Dev. Ind. Pharm. 24 (1998) 327-336; DOI: 10.3109/03639049809085627.